Document is current
Any future updates will be listed below
-
Authors
Sigurjonsdottir, Gudbjörg
De Marchi, Tommaso
Ehinger, Anna
Hartman, Johan
Ullén, Susann
Leandersson, Karin
Bosch, Ana
Staaf, Johan
Killander, Fredrika
Niméus, Emma
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02306096 at ClinicalTrials.govDocuments that mention this clinical trial
Monitoring ctDNA dynamics in early breast cancer using a novel ultra-sensitive tumor-informed structural variant approach combining whole-genome sequencing and multiplex dPCR.
https://doi.org/10.1200/jco.2024.42.16_suppl.568
Alternative splicing and ACMG-AMP-2015-based classification of PALB2 genetic variants: an ENIGMA report
https://doi.org/10.1136/jmedgenet-2018-105834
Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment
https://doi.org/10.1007/s10549-019-05326-5
Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer: results from a population-based cohort
https://doi.org/10.1007/s10549-024-07561-x
-
Funding
Funding for this research was provided by:
Lund University
- License Information
-
More Information
Article History
Received: 28 May 2024
Accepted: 13 November 2024
First Online: 10 December 2024
Declarations
:
: The authors declare no competing interests except for JH who has received speaker's honoraria or advisory board remunerations from Roche, Novartis, Pfizer, EliLilly, MSD, Veracyte and ExactSciences, has received institutional research support from Cepheid, Roche and Novartis and is a co-founder and shareholder of Stratipath AB.
: The SCAN-B study is approved by the Regional Ethical Review Board in Lund, Sweden (applicable registration number 2009/658, 2015/277, 2016/742, 2018/267, and 2019/01252). All the enrolled SCAN-B patients provided written informed consent. The study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
